Nu Skin Enterprises, Inc.
NUS- Exchange
- NYSE
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- SEC CIK
- 0001021561
No open-market purchases or sales by Nu Skin Enterprises, Inc. insiders were filed in the last 90 days; 162 institutions reported holding it in 13F filings for Q2 2026, worth $191.1M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Nu Skin Enterprises, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 273
- −2 vs. Q1 2021
- Shares held
- 41.4M
- +1.64M (+4.1%) vs. Q1 2021
- Total value
- $2.35B
- +$241.9M (+11.5%) vs. Q1 2021
- New holders
- 37
- 104 more added
- Sold out
- 39
- 88 more reduced
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NUS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 162 | $191.1M |
| Q1 2026 | 178 | $264.8M |
| Q4 2025 | 187 | $354.8M |
| Q3 2025 | 194 | $441.6M |
| Q2 2025 | 180 | $289.7M |
| Q1 2025 | 195 | $263.7M |
| Q4 2024 | 201 | $259.4M |
| Q3 2024 | 203 | $285.1M |
| Q2 2024 | 202 | $442.8M |
| Q1 2024 | 198 | $548.1M |
| Q4 2023 | 212 | $794.4M |
| Q3 2023 | 212 | $870.1M |
| Q2 2023 | 219 | $1.43B |
| Q1 2023 | 205 | $1.77B |
| Q4 2022 | 218 | $1.89B |
| Q3 2022 | 207 | $1.47B |
| Q2 2022 | 223 | $1.91B |
| Q1 2022 | 239 | $2.06B |
| Q4 2021 | 258 | $2.14B |
| Q3 2021 | 246 | $1.62B |
| Q2 2021 | 273 | $2.35B |
| Q1 2021 | 276 | $2.11B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Nu Skin Enterprises, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wealthcare Advisory Partners LLC | 0 | $0 | 0.00% | −350−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Hillsdale Investment Management Inc. | 0 | $0 | 0.00% | −180−100.0% | Sold out |
| Wealthcare Capital Management LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Alpha DNA Investment Management LLC | 0 | $0 | 0.00% | −93−100.0% | Sold out |
| American Portfolios Advisors | 0 | $0 | 0.00% | −54−100.0% | Sold out |
| Ameritas Investment Company, LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Twin Tree Management, LP | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Lowe Wealth Advisors, LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| USA Financial Portformulas Corp | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Berman Capital Advisors, LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Mach-1 Financial Group, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| BBVA USA Bancshares, Inc. | – | – | – | – | Not filed |